Alejandro Escobar-Peso

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 10

Top Topics

Cognitive Decline

Anti Inflammatory

Cerebral Ischemia

Top Venues

International journal of molecular sciences

Antioxidants (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Alejandro Escobar-Peso, Emma Martínez-Alonso, Jaime Masjuan, Alberto Alcázar
Development of Pharmacological Strategies with Therapeutic Potential in Ischemic Stroke. Antioxidants (Basel, Switzerland) 12 (12) (2023)
Alejandro Escobar-Peso, Emma Martínez-Alonso, Jaime Masjuan, Alberto Alcázar
Development of Pharmacological Strategies with Therapeutic Potential in Ischemic Stroke. Antioxidants (Basel, Switzerland) 12 (12) (2023)
Emma Martínez-Alonso, Alejandro Escobar-Peso, Natalia Guerra-Pérez, Marcel Roca, Jaime Masjuan, Alberto Alcázar
Dihydropyrimidinase-Related Protein 2 Is a New Partner in the Binding between 4E-BP2 and eIF4E Related to Neuronal Death after Cerebral Ischemia. International journal of molecular sciences 24 (9) (2023)
Emma Martínez-Alonso, Alejandro Escobar-Peso, Natalia Guerra-Pérez, Marcel Roca, Jaime Masjuan, Alberto Alcázar
Dihydropyrimidinase-Related Protein 2 Is a New Partner in the Binding between 4E-BP2 and eIF4E Related to Neuronal Death after Cerebral Ischemia. International journal of molecular sciences 24 (9) (2023)
Emma Martínez-Alonso, Alejandro Escobar-Peso, Natalia Guerra-Pérez, Marcel Roca, Jaime Masjuan, Alberto Alcázar
Dihydropyrimidinase-Related Protein 2 Is a New Partner in the Binding between 4E-BP2 and eIF4E Related to Neuronal Death after Cerebral Ischemia. International journal of molecular sciences 24 (9) (2023)
José M Alonso, Alejandro Escobar-Peso, Israel Fernández, Alberto Alcázar, José Marco-Contelles
Improving the Efficacy of Quinolylnitrones for Ischemic Stroke Therapy, QN4 and QN15 as New Neuroprotective Agents after Oxygen-Glucose Deprivation/Reoxygenation-Induced Neuronal Injury. Pharmaceuticals (Basel, Switzerland) 15 (11) (2022)
Emma Martínez-Alonso, Alejandro Escobar-Peso, Alicia Aliena-Valero, Germán Torregrosa, Mourad Chioua, Rocío Fernández-Serra, Daniel González-Nieto, Youness Ouahid, Juan B Salom, Jaime Masjuan Vallejo, José Marco-Contelles, Alberto Alcázar
Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke. Antioxidants (Basel, Switzerland) 11 (6) (2022)
Emma Martínez-Alonso, Natalia Guerra-Pérez, Alejandro Escobar-Peso, Lorena Peracho, Rocío Vera-Lechuga, Antonio Cruz-Culebras, Jaime Masjuan, Alberto Alcázar
Phosphorylation of Eukaryotic Initiation Factor 4G1 (eIF4G1) at Ser1147 Is Specific for eIF4G1 Bound to eIF4E in Delayed Neuronal Death after Ischemia. International journal of molecular sciences 23 (3) (2022)
Emma Martínez-Alonso, Natalia Guerra-Pérez, Alejandro Escobar-Peso, Ignacio Regidor, Jaime Masjuan, Alberto Alcázar
Differential Association of 4E-BP2-Interacting Proteins Is Related to Selective Delayed Neuronal Death after Ischemia. International journal of molecular sciences 22 (19) (2021)
José M Alonso, Alejandro Escobar-Peso, Alejandra Palomino-Antolín, Daniel Diez-Iriepa, Mourad Chioua, Emma Martínez-Alonso, Isabel Iriepa, Javier Egea, Alberto Alcázar, José Marco-Contelles
Privileged Quinolylnitrones for the Combined Therapy of Ischemic Stroke and Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)